Sudarshan Pharma Industries Ltd
Ticker: SUDARSHAN
Decent
52/100
☆ Add to Watchlist
Investing Reference
Price
26.40
Market Cap
635.34
Debt/Equity
1.2985
ROE %
13.126
PB
4.8322
Promoter %
57.390
Pledge %
0.000
1Y Rev Growth %
8.886
5Y Rev Growth %
27.952
NP Margin %
3.144
NP Margin 5Y Avg %
1.994
Trading Reference
1M Return %
-10.841
6M Return %
-10.660
1Y Return %
-33.088
% Away 52W High
102.652
% Away 52W Low
6.926
Daily Volume
88000
Investment Verdict
Risky
Score 57/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 17/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Sudarshan Pharma Industries Ltd is currently trading near a key support level, with recent volume indicating accumulation. If it breaks above the resistance level at 350, it could see an upside potential of approximately 20%. Conversely, if it falls below the support level at 300, there is a downside risk of about 15%.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Apex Frozen Foods Ltd
Apex Frozen Foods Ltd shows potential for growth, but faces challenges in profitability and market competition.
View details
M
Menon Bearings Ltd
Menon Bearings Ltd shows potential in a stable industry, but faces challenges in profitability and market sentiment.
View details
B
Bright Outdoor Media Ltd
Bright Outdoor Media Ltd shows potential in a growing sector, but faces challenges in execution and profitability.
View details
T
Transpek Industry Ltd
Transpek Industry Ltd shows decent potential but faces challenges in profitability and market conditions.
View details
I
IFB Agro Industries Ltd
The stock shows several weaknesses in growth, profitability, and market sentiment, suggesting caution for investors.
View details
S
Shree Refrigerations Ltd
Shree Refrigerations Ltd shows potential in a growing sector but faces challenges in profitability and market sentiment.
View details
H
Hindustan Composites Ltd
Hindustan Composites Ltd shows potential in a growing sector, but inconsistent growth and execution risks warrant caution.
View details
D
Dreamfolks Services Ltd
Dreamfolks Services Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
U
Urja Global Ltd
Urja Global Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
R
RPP Infra Projects Ltd
RPP Infra Projects Ltd shows potential in a growing sector, but faces challenges in execution and financial stability.
View details
O
Onward Technologies Ltd
Onward Technologies Ltd shows potential but faces challenges in growth consistency and market competition.
View details
S
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd shows potential in a future-ready sector, but faces challenges in growth consistency and market sentiment.
View details
J
Jayant Agro-Organics Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Cellecor Gadgets Ltd
Cellecor Gadgets Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside concerns in governance and market sentiment.
View details
G
Gloster Ltd
Gloster Ltd shows potential for growth but faces challenges in profitability and market competition.
View details
S
State Trading Corporation of India Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Sudarshan Pharma Industries Ltd is a leading player in the Indian pharmaceutical sector, dedicated to delivering high-quality healthcare solutions. Catering to a diverse clientele, including hospitals and pharmacies, the company focuses on innovation and sustainability in its product offerings. With a commitment to excellence and regulatory compliance, Sudarshan Pharma plays a vital role in enhancing public health. Its strong R&D capabilities and strategic partnerships ensure a steady pipeline of advanced pharmaceutical products, making it a trusted choice for healthcare providers across India.
- Established leader in the Indian pharmaceutical industry
- Focus on high-quality healthcare solutions
- Diverse clientele including hospitals and pharmacies
- Strong commitment to innovation and sustainability
- Robust R&D capabilities for advanced products
- Trusted choice for healthcare providers across India
Investment Thesis
Sudarshan Pharma Industries Ltd presents a compelling investment opportunity due to its robust promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth and profitability, making it a strong contender in the pharmaceutical sector.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers substantial growth opportunities.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Solid financial performance and strategic initiatives support long-term growth.
- Commitment to innovation and quality positions the company favorably in the market.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceutical products
- Expansion into international markets
- Strong product pipeline development
- Strategic partnerships with healthcare providers
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in the sector
- Supply chain disruptions
- Fluctuating raw material costs
Peer Perspective
Sudarshan Pharma Industries Ltd trades at a discount to peers like Aarti Industries and Vinati Organics, primarily due to margin volatility; a stable margin outlook could trigger a rerating in its valuation.
Future Outlook
Sudarshan Pharma Industries Ltd is well-positioned for growth, driven by strong market demand and innovative product offerings; however, successful execution and stringent cost control will be critical to achieving its long-term objectives.
AI FAQs for Retail Users
- Q: What does Sudarshan Pharma Industries Ltd do?A: Sudarshan Pharma Industries Ltd manufactures and sells pharmaceutical products, focusing on quality and innovation.
- Q: Is Sudarshan Pharma a good investment?A: Investing in Sudarshan Pharma depends on your financial goals and risk tolerance. Research is recommended.
- Q: What are the recent developments in Sudarshan Pharma?A: Recent developments include new product launches and expansion into emerging markets.
- Q: How can I buy shares of Sudarshan Pharma?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What are the risks of investing in Sudarshan Pharma?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
📊 Stock Investment Checklist (100 Points)
Sudarshan Pharma Industries Ltd • Updated: 2025-09-17 17:05:46
-
10BusinessHighThe sector is growing with increasing demand for pharmaceuticals, but the company lacks a significant competitive moat.
-
10GrowthHighRevenue growth has been inconsistent, with some fluctuations in profit margins.
-
8ProfitabilityHighROE and ROCE are moderate, but cash flow generation is not stable.
-
9ValuationHighValuation metrics are slightly above industry averages, indicating potential overvaluation.
-
7BalanceHighThe company has manageable debt levels, but liquidity ratios are on the lower side.
-
6GovernanceGoodPromoter holding is decent, but there are concerns regarding pledging of shares.
-
5DriversGoodGrowth drivers are limited, with execution risks in expanding product lines.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity and mixed price action.
Final Score & Verdict
Score 52 / 100
• Decent
Sudarshan Pharma Industries Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks. Caution is advised for investors.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100